PHARMADAX Trademark

Trademark Overview

On Thursday, June 7, 2018, a trademark application was filed for PHARMADAX with the United States Patent and Trademark Office. The USPTO has given the PHARMADAX trademark a serial number of 87952390. The federal status of this trademark filing is REGISTERED as of Tuesday, August 4, 2020. This trademark is owned by Pharmadax USA, Inc.. The PHARMADAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
pharmadax

General Information

Serial Number87952390
Word MarkPHARMADAX
Filing DateThursday, June 7, 2018
Status700 - REGISTERED
Status DateTuesday, August 4, 2020
Registration Number6119507
Registration DateTuesday, August 4, 2020
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 6, 2018

Trademark Statements

Description of MarkThe mark consists of the word "PHARMADAX" in capital letters with "PHARMA" in bold letters and "DAX" in non-bold letters.
Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 14, 2018
Primary Code005
First Use Anywhere DateTuesday, March 1, 2016
First Use In Commerce DateTuesday, March 1, 2016

Trademark Owner History

Party NamePHARMADAX INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEW TAIPEI CITY 23553
TW
Party NamePharmadax USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWalnut, CA 91789
Party NamePharmadax USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NamePharmadax USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Thursday, June 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 25, 2018ASSIGNED TO EXAMINER
Monday, June 11, 2018NEW APPLICATION ENTERED
Tuesday, November 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 30, 2019TEAS STATEMENT OF USE RECEIVED
Monday, December 30, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, September 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 28, 2019SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2019SOU EXTENSION 1 FILED
Friday, June 28, 2019SOU EXTENSION 1 GRANTED
Wednesday, January 15, 2020NON-FINAL ACTION E-MAILED
Monday, December 30, 2019SOU EXTENSION 2 FILED
Monday, December 30, 2019USE AMENDMENT FILED
Wednesday, January 8, 2020SOU EXTENSION 2 GRANTED
Wednesday, January 8, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2020SU - NON-FINAL ACTION - WRITTEN
Wednesday, January 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 24, 2020SOU TEAS EXTENSION RECEIVED
Saturday, June 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 4, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 10, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, August 14, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, June 21, 2020ASSIGNED TO LIE
Wednesday, June 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 30, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 4, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

pharmadax gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related